Author: Lucy Parsons

GSK’s anti-BCMA drug Blenrep wins US approval

First anti-BCMA therapy to be approved anywhere in the world

Study co-led by UCL and the London School of Hygiene & Tropical Medicine

Drug reduced annual rate of asthma exacerbations by 49%

Drug is first biologic in Europe to be approved with a dose reduction label for axSpA patients

Draft guidance says some commonly used drug treatments should be avoided

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN